Filter your results
- 3
- 3
- 3
- 2
- 1
- 3
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromesAnnals of Hematology, 2022, 101 (12), pp.2633-2643. ⟨10.1007/s00277-022-04993-7⟩
Journal articles
hal-03876188v1
|
|||
Luspatercept (RAP-536) modulates oxidative stress without affecting mutation burden in myelodysplastic syndromesAnnals of Hematology, 2022, 101 (12), pp.2633-2643. ⟨10.1007/s00277-022-04993-7⟩
Journal articles
inserm-03874959v1
|
|||
Extracellular vesicles from myelodysplastic mesenchymal stromal cells induce DNA damage and mutagenesis of hematopoietic stem cells through miRNA transferLeukemia, 2020, 34 (8), pp.2249-2253. ⟨10.1038/s41375-020-0738-8⟩
Journal articles
hal-03969633v1
|